British Drugmaker Seeks to Market Malaria Vaccine

British drugmaker GlaxoSmithKline is seeking approval to market the world’s first malaria vaccine, after trials showed that it significantly cut cases of the disease in children.

Results from latest clinical trial of the RTS,S vaccine were unveiled at a conference in Durban, South Africa on Tuesday.

It showed that after 18 months of follow-up, the vaccine halved the number of malaria cases in young children and reduced the number of cases in infants by about 25 percent.

The trials were …